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Background: As people live longer, their risk of disability increases. Disability affects quality of life and increases
health and social care costs. Preventing or delaying disability is therefore an important objective, and identifying
an effective intervention could improve the lives of many older people. Observational and interventional evidence
suggests that physical activity may reduce the risk of age-related disability, as assessed by physical performance
measures. However it is unclear what approach is the most cost-effective intervention in changing long-term
physical activity behaviour in older adults. A new theory-driven behavioural intervention has been developed, with
the aim of increasing physical activity in the everyday lives of older adults at risk of disability. This pilot study tests
the feasibility and acceptability of delivering this intervention to older adults.
Methods/Design: A randomised controlled trial (RCT) design will be used in the pilot study. Sixty patients aged 65
years and older will be recruited from primary care practices. Patients will be eligible to participate if they are
inactive, not disabled at baseline, are at risk of developing disability in the future (Short Physical Performance
Battery score <10/12), and have no contraindications to physical activity. Following baseline measures, participants
will be randomised in a 2:1 ratio to the intervention or to a control arm and all participants will be followed-up after
6 months. Those randomised to the intervention arm will receive sessions with a trained Physical Activity Facilitator,
delivering an intervention based on self-determination theory. Control participants receive a booklet on healthy
ageing. The main outcomes of interest are recruitment, adherence, retention and acceptability. Data will also be
collected on: self-report and accelerometer-recorded physical activity; physical performance; depression; wellbeing;
cognitive function; social support; quality of life, healthcare use, and attitudes to physical activity. A mixed-methods
process evaluation will run alongside the RCT.
Discussion: The intervention, if effective, has the potential to reduce disability and improve quality of life in older
adults. Before proceeding to a full-scale trial a pilot trial is necessary to ensure intervention feasibility and
acceptability, and that the intervention shows evidence of promise.
Trial registration: Current Controlled Trials ISRCTN80470273. Registered 25 October 2013.
Keywords: Physical activity, Ageing, Disability, Randomised controlled trial, Complex intervention, Self-determination
theory, Physical performanceBackground
Ageing, disability, and physical activity
Life expectancy in the UK has been increasing, and re-
cent advances in medical science have reduced deaths
from heart disease and cancer, resulting in a greater
population of older adults with increasing prevalence of
comorbidities. Around one third of babies born in 2013* Correspondence: Gemma.morgan@bristol.ac.uk
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unless otherwise stated.are expected to reach their 100th birthday [1], and in
2011 adults aged 65 years and over comprised 16% of
the population [2]. It is important that efforts to extend
life do not overshadow efforts to enable older adults to
live independently and to function well into old age.
Failing to achieve this has consequences for both the in-
dividual suffering from a diminished quality of life, and
for a society trying to contain the costs associated with
an increased demand for health and social care [3].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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disability. The classic model of disability by Nagi [4] de-
scribed a step-wise pathway from physiological pathology
to performance limitations, which affect social roles and
tasks, causing disability. Verbrugge and Jette [5] and more
recently Rejeski et al. [6] have identified key modifiers
along the disability pathway, including lifestyle behaviours
and psychosocial attitudes. Researchers have been inter-
ested in identifying those key modifiers or risk factors, as
they may provide an opportunity to intervene and prevent,
or at least delay, age-related disability.
There is now a considerable body of observational re-
search suggesting that physical activity is associated with
physical function in later life, and that physical activity
interventions in community-dwelling older adults may
prevent or delay disability. Recommendations from the
2011 Chief Medical Officers’ report on physical activity
advised that adults over 65 years undertake at least
2.5 hours of moderate intensity physical activity per
week, including sustained bouts of 10 minutes [7], yet we
know from cross-sectional surveys that many older adults
are not meeting this target [8]. It therefore remains a key
challenge to identify a cost-effective intervention that can
increase physical activity in the long-term and can prevent
disability in older adults in the UK.
Physical Activity Facilitation (PAF)
An existing intervention, successfully used to increase
physical activity in adults with depression, has been
modified and developed for application to a population
of older adults at risk of disability. Physical Activity
Facilitation (PAF) was first developed for the TREAD
trial, aiming to help adults with depression by using PAF
facilitators to deliver behaviour change techniques using
motivational interviewing and counselling strategies [9].
In the TREAD study patients randomised to the inter-
vention (PAF) arm were twice as likely to be physically
active compared to controls at 8 months, and this effect
was sustained beyond cessation of the intervention. The
PAF intervention is based upon self-determination the-
ory [10], which purports that for an individual to modify
their behaviour three core psychological needs must be
met: the need for autonomy (having control and choice
over activity); for competence (feeling capable about
doing something); and for relatedness (feeling connected
to and supported by others). The rationale and design of
the original PAF intervention is described elsewhere
[11]. In summary, the PAF facilitator acts as the main
agent of change, and aims to address the core psycho-
logical needs of participants through face-to-face and
telephone sessions.
Older adults at risk of disability may share common
features with adults with depression such as loneliness,
lack of confidence, and apathy and it is, therefore,possible that the PAF intervention will be effective in
changing behaviour in the older adult population. The
original PAF intervention has been further developed
and modified to relate to a population of community-
dwelling older adults, who are at risk of disability and
therefore often in poorer physical health. Evidence of the
motivators, barriers and challenges facing this popula-
tion has been collected from a systematic synthesis of
the qualitative literature on older adults and these data
have led to the evolution and adaptation of the interven-
tion for the PACE study. The PAF sessions are designed to
be highly tailored to the individual participant’s circum-
stances, whilst staying true to the core principles of self-
determination theory. The focus is on 'lifestyle' physical
activity, that is including activity into an individual’s day-
to-day life and daily routine, though participants interested
in more formal exercise or sport sessions are also sup-
ported to achieve this.
Measuring disability
In order to assess whether physical activity interventions
make a clinically significant difference to the lives of
older adults, it is necessary to identify an appropriate
measure of disability. This is challenging because Nagi’s
concept of disability requires a judgement of impairment
in an individual’s social role which is difficult to assess in
a research clinic setting. Previous studies have used a
variety of outcomes including severe mobility limitation,
nursing home admission, and self-reported measures of
activities of daily living (ADL) [12]. However there are
theoretical and practical limitations to these tools, par-
ticularly in randomised controlled trials (RCTs) where
events such as nursing home admission may be rare,
and self-report measures are susceptible to reporting bias,
especially when participants are unblinded [13]. A meas-
ure of disability more recently used in research settings is
‘mobility disability’, that is the inability to complete a mea-
sured walking track within a specified time. Mobility dis-
ability is thought to represent a close approximation to
disability, as it is assumed that the ability to mobilise is
central to an older individual’s quality of life and ability to
fulfil the activities of daily living [14].
Helpfully, a set of objective physical performance cri-
teria has been identified that provides convincing prog-
nostic information of the risk of age-related disability.
The prognostic tool comprises measures of standing bal-
ance, gait speed, and chair rise and is known as the Short
Physical Performance Battery (SPPB) [15]. Scores on the
SPPB have been found to be highly predictive of new-
onset disability, both self-reported and objective [16], and
can predict loss of mobility, hospitalization, nursing home
admission, and death. The SPPB measures may therefore
be used as a screening tool to identify patients most likely
to benefit from an intervention, and this approach has
Morgan et al. Trials  (2015) 16:91 Page 3 of 7been used in several large-scale physical activity studies.
In addition to their prognostic value, the SPPB, along
with grip strength, also reflect an individual’s muscle
strength and motor control. Since these functions are
necessary for the basic tasks of independent living, the
SPPB and grip strength are also appropriate outcome
measures in studies looking at prevention of disability -
they can be considered intermediary or proxy measures
of disability.
Hypotheses
It is hypothesised that the PAF intervention will be ef-
fective in increasing physical activity in older adults at
risk of disability, and that the increased physical activity
will lead to a reduction in disability and/or improved
physical performance, as measured using a timed walk
and the SPPB.
Objectives
Before proceeding to a definitive RCT, it is important to
ensure the feasibility of delivering both the intervention
and a full-scale trial, as noted in the Medical Research
Council (MRC) framework for the evaluation of complex
interventions [17]. Therefore, an exploratory pilot trial is
necessary to ensure that the PAF intervention may be
delivered as intended; to ensure the intervention reaches
the intended population; and to ensure that the recruit-
ment and trial processes are successful and acceptable to
participants.
The objectives of the exploratory pilot trial are:
1) To establish whether the PAF intervention is
acceptable for the target population, and to collect
data to test elements of the theoretical basis of the
study (the programme theory)
2) To assess the feasibility of undertaking a definitive and
full-scale RCT of the PAF intervention in the target
population, evaluating the process of recruitment,
screening, randomisation, collection of baseline and
outcome data
3) To explore and describe any trial design aspects that
may require modification before proceeding to a
full-scale trial
4) To provide estimates of the variability around the
important parameters, necessary to calculate the
sample size and resources required for an
adequately-powered full-scale trial.
As this study investigates a complex social intervention,
the aim is to undertake a ‘realist RCT’, establishing what
works, for whom, under what circumstances [18]. There
will, therefore, be considerable emphasis on process evalu-
ation and qualitative methodologies to understand under-
lying mechanisms.Methods
Study design
The study is funded by the National Institute of Health
Research (NIHR) as part of a Doctoral Research Fellowship
award. Ethical approval was received from the Humber
Bridge Research Ethics Committee (REC), later transferred
to South Yorkshire REC (reference: 13/YH/0319).
The trial is a rater-blinded controlled trial using a con-
cealed computer-generated random allocation sequence.
Recruitment will run between April 2014 and January
2015. Outcomes are assessed at 6 months by an independ-
ent research nurse blinded to the allocation sequence.
Qualitative interviews and observations will form part of a
process evaluation to explore acceptability and assess
intervention fidelity.
Recruitment and randomisation
Sixty adults aged 65 years and over will be recruited from
primary care practices across Bristol and the surrounding
area. As this is a pilot study designed to explore feasibility,
it will not be powered for a primary outcome. The sample
size was selected to ensure sufficient numbers were avail-
able in both arms to provide useful data on process evalu-
ation measures and variability in outcome measures. This
sample size is consistent with other pilot studies of phys-
ical activity interventions [19,20]. The study will be open
to both male and female participants; full eligibility criteria
are listed in Table 1.
Up to six primary care practices will be selected from
wards of differing deprivation level. We aim to evaluate
alternative methods of recruitment in the study: conven-
tional postal invitation and opportunistic recruitment by
a researcher sitting in the waiting room. The effective-
ness, acceptability, and feasibility of each recruitment
method will be evaluated.
For practices using the postal invitation approach, gen-
eral practitioners (GPs) will randomly select 375 patients
from their list of eligible patients, excluding those they
know to be ineligible, or those whom it would be in-
appropriate to approach (for example, those suffering
from a recent bereavement). An invitation letter with a
study information sheet will be sent to these patients.
The invitation letter will contain a reply slip for inter-
ested individuals to make contact with the study team.
Non-responders will be sent one reminder invitation. In-
terested individuals recruited through postal interviews
will undergo telephone screening initially; this will enable
exclusion of individuals who are already meeting the mini-
mum recommended levels of physical activity, or who are
unable to walk for a quarter of a mile. Patients eligible at
this stage are invited to a clinical screening clinic.
In practices using opportunistic waiting room recruit-
ment, older patients attending the practice for appoint-
ments will be approached by a researcher prior to their
Table 1 Eligibility criteria
Inclusion criteria
Aged 65 years or older
Community-dwelling, including those in sheltered accommodation
Inactive: undertaking less than 150 minutes of moderate, or 75 minutes of vigorous, physical activity per week
Non-disabled at baseline: able to complete a 4-metre walk at a speed of 0.8 m/s or greater, without sitting,
leaning, using a walking aid or another person
At risk of subsequent disability: scoring less than 10 out of 12 on the SPPB
Exclusion criteria
Unable to participate in the intervention or study due to speech, language, or sensory problems
Resident in a nursing home
Plans to move out of the area within 6 months of the screening clinic visit or to be away for more than 8
consecutive weeks during this period
Currently participating in an exercise-on-prescription or rehabilitation programme or study
A documented or patient-reported medical condition including but not limited to: severe arthritis; lung disease
requiring home oxygen; serious cardiovascular disease; past history of cardiac arrest; implantable cardioverter
defibrillator; neuromuscular or musculoskeletal conditions exacerbated by exercise; moderate or severe cognitive
impairment or dementia; severe uncontrolled psychiatric illness; multiple falls
Investigator concern about an individual’s safety or ability to adhere to the intervention
Abbreviation: SPPB Short Physical Performance Battery.
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bility criteria at this stage, and those interested and po-
tentially eligible will be invited to a clinical screening
appointment.
At the clinical screening appointment patients will
be objectively assessed as ‘non-disabled’ using a timed
4-metre walk. This assessment is practical and highly
predictive (>90%) of successfully completing the well-
established 400-metre walk test within 15 minutes
[21]. Individuals will also be assessed as ‘at risk of dis-
ability’ using the SPPB. Scores of less than 10 out of 12
on the SPPB represent up to a 5-fold increased risk of
new-onset disability within 4 years [16]; this will be the
threshold for inclusion in the PACE study and is con-
sistent with the threshold used in other physical activ-
ity intervention trials [14].
Before the clinical screening appointment, potentially
eligible patients will be sent a questionnaire in the post
for prior completion, containing self-report measures of
physical activity [22], motivation for physical activity,
and mood [23]. At the clinical screening appointment
patients will be asked about specific medical conditions
that may mean physical activity is contraindicated, such
as unstable angina or critical heart valve disease, based
upon the eligibility criteria. Should the study investigator
have concerns about the suitability of a patient for the
study then these concerns may be discussed with the pa-
tient’s GP before enrolment.
Eligible patients will provide informed written consent
and will be enrolled in the study immediately following the
clinical screening appointment. Further baseline measureswill be completed at this time (Table 2). Participants will
also be provided with an ActiGraph GT1M accelerometer
to be worn on the hip for 7 days and a journey log to docu-
ment trips made during this period.
Randomisation will use a sequence minimising on age,
gender, and GP practice. This will be computer-generated
by the Bristol Randomised Trials Collaboration, a UK
Clinical Research Collaboration (UKCRC)-registered
clinical trials unit. The randomisation ratio will be 2:1
favouring the intervention arm (40 participants) over
the control arm (20 participants). Once the participant
has been allocated to either the intervention or control
arm, this assignment will be made available to the re-
searcher and participant: it is not possible to blind par-
ticipants to the treatment allocation. Participants’ GPs
are contacted following each enrolment and are briefed
about the exclusion criteria, to ensure no patient is en-
rolled inappropriately.
Treatment arms
Participants randomised to the intervention arm will be
contacted by a trained PAF facilitator. It is anticipated
that if cost-effective, the PAF intervention could be de-
livered by nurses or healthcare workers in community
settings and so a background in physical activity or
healthcare is a desirable, but not essential criteria for ap-
pointment. For the pilot trial 2 PAFs will be appointed
and will receive a 3-day training course covering the the-
oretical background to the intervention, the principle be-
haviour change strategies relevant to the intervention, and
an introduction to communication using motivational
Table 2 Baseline and follow-up measures
Month 0 Month 0 Month 6
Measure Home Baseline visit Follow-up visit
General
Medical and drug history ✓
Sociodemographic details ✓
Athropometry (weight ± height) ✓ ✓
Physical function and disability
Timed 4-m walk ✓ ✓
Short Physical Performance Battery (SPPB) ✓ ✓
Grip strength ✓ ✓
Lawton’s scale of instrumental ADL ✓ ✓
Physical activity
ActiGraph GT1M accelerometer ✓ ✓
PASE questionnaire ✓ ✓
Mood
Geriatric Depression Scale (15-part) ✓ ✓
Cognitive
Montreal Cognitive Assessment (MoCA) ✓ ✓
Process measures
Physical activity outcome expectations scale ✓ ✓
Motivation for physical activity (BREQ-2) scale ✓ ✓
Autonomy support scale (intervention group) ✓
Psychological need satisfaction in exercisea ✓ ✓
Social Support Questionnaire (SSQ) ✓ ✓
Basic Psychological Needs Scale ✓ ✓
Quality of Life
European Quality of Life 5 Dimensions (EQ-5D) ✓ ✓
ICEpop CAPability measure for Older people ✓ ✓
Health service use
Primary and secondary care consultations ✓
Care home and hospital admission ✓
aNB in this scale the term 'exercise' will be replaced by 'physical activity'.
ADL, activities of daily living. BREQ, Behavioural Regulation in Exercise Questionnaire.
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be provided, and training sessions will be evaluated by
observation, audio recording and transcription, and
PAF feedback. PAF facilitators will have access to regu-
lar and frequent supervision and support throughout
the trial.
Each intervention participant will receive an initial
face-to-face PAF session, and after this participants will
be offered up to two further face-to-face sessions, and
up to nine telephone support sessions. These sessions
are not at fixed intervals but are flexibly tailored to suit
the participant and their progress. All intervention par-
ticipants are offered the opportunity to involve aspouse, friend or close social partner in the sessions, or
in supporting them to increase their activity levels.
Worksheets designed to assist with behaviour change
techniques such as goal setting and feedback are avail-
able for participants to use if they choose. PAF facilita-
tors will keep detailed logs of each session and will
reflect on how they are addressing the theoretical com-
ponents of the intervention.
Participants allocated to the control arm will receive a
booklet on healthy ageing, containing health promotion
messages such as healthy diet, physical activity, and falls
prevention. This is produced by Age UK, is publicly avail-
able and is, therefore, compatible with ‘usual care’.
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The main quantitative outcomes will be recruitment, ad-
herence, and retention rates, in order to inform the design
of a future full-scale trial. All participants will be followed-
up 6 months after enrolment, and the baseline measures
undertaken at month 0 will be repeated by a trained prac-
tice nurse or healthcare assistant who is blinded to the
treatment allocation. Simple descriptive statistics will be
used to describe the distribution and baseline variability of
all outcomes of interest, and effect sizes may be calculated
to assess for evidence of promise, whilst accepting that the
study will not be powered to provide strong evidence
against the null hypothesis. The variability of the parame-
ters will contribute to a sample size calculation for the
full-scale trial.
In the full-scale trial the primary outcomes will be the
ability to complete the 4-metre walking test and the
SPPB. Secondary outcomes will include physical activity
(measured objectively and by self-report); body mass
index (BMI); grip strength; and measures using the fol-
lowing tools: Lawton’s self-reported ADL [24]; Geriatric
Depression Scale [23]; Montreal Cognitive Assessment
(MoCA) [25]; and the Social Support Questionnaire
(SSQ) [26]. Costs of the intervention will be docu-
mented, and healthcare use estimated from primary care
records. The cost-effectiveness of the intervention may
be estimated using data from the European Quality of
Life 5 Dimensions (EQ-5D) [27] and ICECAP-O [28]
quality of life tools. Full details of the measures collected
in the pilot trial are shown in Table 2.
Adverse events may be expected in physical activity tri-
als. Participants in both study arms will be asked about ad-
verse events regularly; all adverse events will be reviewed
and recorded. Serious adverse events will be reported to
the sponsor and an independent clinical geriatrician, who
will be responsible for discussing any concerns with the
sponsor and advising the study team accordingly.
Process evaluation
In order to evaluate whether the intervention operates
as anticipated, process measures of physical activity ex-
pectations, motivations, and psychological needs satis-
faction will be collected. These data will be supported by
data gathered from qualitative interviews to assess
whether the intervention is functioning at the levels ex-
pected. PAF sessions will be audio-recorded where pos-
sible and observed, allowing assessment of fidelity of the
intervention. A purposefully-selected sample of partici-
pants will be asked to participate in a semi-structured
interview. The interview will explore experiences of the
intervention and trial, and attitudes and beliefs about
physical activity. In addition, semi-structured interviews
will be held with GPs, nurses, and primary care staff in-
volved in the PACE study, and with the PAF facilitators,to explore their attitudes to the intervention and their
experiences of the pilot trial. Interviews will be audio re-
corded, transcribed, and analysed using the Framework
approach [29].
Trial Advisory Committee
As this is a pilot study, no formal data monitoring com-
mittee will be convened. However the study has a Trial
Advisory Committee (TAC), comprising an academic gen-
eral practitioner, clinical geriatrician, and academics expe-
rienced in trial design, physical activity interventions in
older adults, and statistics. The TAC provides advice on
study design, adverse events, and data analysis.
Discussion
This pilot RCT and exploratory study aims to assess
the feasibility of using a novel theory-based interven-
tion, customised for an older population, as a means of
increasing physical activity and physical performance.
When evaluating a new individual-level intervention,
first targeting those with the greatest capacity to bene-
fit often leads to the most efficient use of limited re-
sources. It is thus important to focus initially on
identifying a healthy population who are ‘at risk’ of fu-
ture disability. Should the intervention appear effective
in this group, it may then be appropriate to evaluate
the intervention whilst adopting a ‘population ap-
proach’, accepting that the individual health gain to in-
dividuals at low risk is unlikely to be as great as to
those at higher risk of disability. Ultimately however, if
the intervention is shown to be cost-effective, eventual
implementation of the PAF intervention in routine
care could impart considerable public health benefits,
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